{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:49:53Z","timestamp":1789019393816,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.023","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T17:31:14Z","timestamp":1681407074000},"page":"3111-3118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil"],"prefix":"10.1016","volume":"41","author":[{"given":"Let\u00edcia B.D.P.","family":"Fortuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe M.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa M.F.","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdtalo M.","family":"Dolores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayara T.","family":"Cardoso-Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia M.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe P.G.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.023_b0005","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204\u201322. 10.1016\/S0140-6736(20)30925-9. Erratum in: Lancet 2020;396:1562."},{"key":"10.1016\/j.vaccine.2023.04.023_b0010","unstructured":"Brazil. Ministry of Health. Sistema de Informa\u00e7\u00f5es Hospitalares do SUS (SIH\/SUS). http:\/\/tabnet.datasus.gov.br\/cgi\/deftohtm.exe?sih\/cnv\/niuf.def; 2019 [accessed 12.19.2022]."},{"key":"10.1016\/j.vaccine.2023.04.023_b0015","unstructured":"Brazil. Ministry of Health. Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o - Sinan Net. MENINGITE - Casos confirmados notificados no Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o - Brasil, http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sinannet\/cnv\/meninbr.def; 2010-2019 [accessed 12.19.2022]."},{"key":"10.1016\/j.vaccine.2023.04.023_b0020","unstructured":"Brazil. Ministry of Health. Informe t\u00e9cnico para implanta\u00e7\u00e3o da vacina pneumoc\u00f3cica conjugada 13-valente em pacientes de risco \u2265 de 5 anos de idade. Bras\u00edlia, DF; 2019."},{"key":"10.1016\/j.vaccine.2023.04.023_b0025","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2017.04.019","article-title":"Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C","volume":"35","author":"Neves","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.023_b0030","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1016\/j.vaccine.2019.07.056","article-title":"Direct effect of the 13-valent pneumococcal conjugate vaccine use on pneumococcal colonization among children in Brazil","volume":"37","author":"Neves","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.023_b0035","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.04.023_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"Serotype Replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries","volume":"28","author":"Hanquet","year":"2022","journal-title":"Europe Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.023_b0045","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dky001","article-title":"Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage","volume":"73","author":"Neves","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2023.04.023_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.543898","article-title":"Characterization of pneumococcal colonization dynamics and antimicrobial resistance using shotgun metagenomic sequencing in intensively sampled South African infants","volume":"8","author":"Manenzhe","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2023.04.023_b0055","doi-asserted-by":"crossref","unstructured":"Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 201;32:165\u201379. 10.1016\/j.vaccine.2013.08.062.","DOI":"10.1016\/j.vaccine.2013.08.062"},{"key":"10.1016\/j.vaccine.2023.04.023_b0060","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.02243-09","article-title":"Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes","volume":"48","author":"Carvalho","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2023.04.023_b0065","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1017\/S0950268817000449","article-title":"Pneumococcal nasopharyngeal carriage among children in Brazil prior to the introduction of the 10-valent conjugate vaccine: a culture- and PCR-based survey","volume":"145","author":"Rodrigues","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.04.023_b0070","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 32nd ed. Clinical and Laboratory Standards Institute; 2022."},{"key":"10.1016\/j.vaccine.2023.04.023_b0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2023.04.023_b0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/mdr.2004.10.313","article-title":"Occurrence and characteristics of erythromycin-resistant Streptococcus pneumoniae strains isolated in three major Brazilian states","volume":"10","author":"Mendon\u00e7a-Souza","year":"2004","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.vaccine.2023.04.023_b0085","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2019.07.043","article-title":"Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil","volume":"37","author":"Brandileone","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.023_b0090","unstructured":"Instituto Adolfo Lutz. Informa\u00e7\u00e3o da vigil\u00e2ncia das pneumonias e meningites bacterianas; 2019. http:\/\/www.ial.sp.gov.br\/resources\/insituto-adolfo-lutz\/publicacoes\/sireva_2019.pdf [accessed 12.28.2022]."},{"key":"10.1016\/j.vaccine.2023.04.023_b0095","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2016.09.027","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in S\u00e3o Paulo, Brazil","volume":"34","author":"Brandileone","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.023_b0100","first-page":"47","article-title":"Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children with acute otitis media in Marrakech","volume":"14","author":"Amari","year":"2022","journal-title":"Morocco Iran J Microbiol"},{"key":"10.1016\/j.vaccine.2023.04.023_b0105","article-title":"Serotype 19A and 6C account for one third of pneumococcal carriage among Belgian day-care children four years after a shift to a lower-valent PCV","author":"Ekinci","year":"2022117","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2023.04.023_b0110","series-title":"Datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasivos bacterianos","first-page":"2017","author":"Panamericana","year":"2014"},{"key":"10.1016\/j.vaccine.2023.04.023_b0115","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1177\/09612033211030549","article-title":"Carriage prevalence, serotype distribution, and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus","volume":"30","author":"Rezende","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2023.04.023_b0120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/1471-2334-13-318","article-title":"Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine","volume":"13","author":"Neves","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.023_b0125","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Informe regional de SIREVA II, 2018. Washington, D.C.: OPS; 2021. 10.37774\/9789275324035."},{"key":"10.1016\/j.vaccine.2023.04.023_b0130","unstructured":"Institut Nacional de Salud, Colombia. SIREVA II. Vigilancia por laboratorio de aislamientos invasores de Streptococcus pneumoniae Colombia 2006-2018. Institut Nacional de Salud, Colombia; 2019. https:\/\/redsirevanetwork.com\/colombia\/ [accessed 12.28.2022]."},{"key":"10.1016\/j.vaccine.2023.04.023_b0135","unstructured":"Institut Nacional de Salud, Colombia. SIREVA II. Vigilancia por Laboratorio de aislamientos invasores deStreptococcus pneumoniaeColombia; 2019. https:\/\/redsirevanetwork.com\/colombia\/ [accessed 12.28.2022]."},{"key":"10.1016\/j.vaccine.2023.04.023_b0140","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/21645515.2021.1874219","article-title":"Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL\u00ae)","volume":"17","author":"Alderson","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.04.023_b0145","unstructured":"U. S. Food and Drug Administration. Vaccines Licensed for Use in the United States. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/vaccines-licensed-use-united-states [accessed 12.28.2022]."},{"key":"10.1016\/j.vaccine.2023.04.023_b0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40265-022-01733-z","article-title":"20-Valent Pneumococcal Conjugate Vaccine: a review of its use in adults","volume":"82","author":"Shirley","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2023.04.023_b0155","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.023_b0160","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.vaccine.2022.06.041","article-title":"Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A","volume":"40","author":"Hao","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.023_b0165","doi-asserted-by":"crossref","unstructured":"Lima EJF, Mello MJG, Albuquerque MFPM, Lopes MIL, Serra GHC, Lima DEP, et al. Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study. BMC Pediatr 2016;16. 10.1186\/s12887-016-0695-6.","DOI":"10.1186\/s12887-016-0695-6"},{"key":"10.1016\/j.vaccine.2023.04.023_b0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jac\/dkab404","article-title":"Azithromycin in patients with COVID-19: a systematic review and meta-analysis","volume":"77","author":"Ayerbe","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:38Z","timestamp":1759404338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":34,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23004152"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}